好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Concussion and Court: The Role Litigation Plays in Time to Recovery.
Neuro Trauma and Sports Neurology
P1 - Poster Session 1 (5:30 PM-7:00 PM)
034

To evaluate whether there is a difference in time to recovery (TTR) between concussion patients who have and have not pursued litigation post injury, and determine what factors might influence someone’s decision to litigate.

An investigation on how litigation influenced TTR in all types of recovery.

A retrospective study of 851 adult and pediatric patients, ages 1-78 (333men and 518women) in a concussion clinic. Injuries included, motor vehicle accidents MVA(n=181), falls(n=140), assaults(n=36), sporting injuries(n=378) and other(n=116). Full and matched samples were studied by symptom endorsement, (headache, dizziness, sleep disturbance, attention/concentration dysfunction and moodiness), litigation/non-litigation and TTR(survival-curve). Secondary analysis reviewed abuse/depression, mechanism-of-injury and symptom type as it related to litigation/non-litigation.

1)     The odds ratio (OR) in the logistic regression model for the unmatched sample shows increasing age, fewer total symptoms (<3symptoms vs.≥3), history of abuse/depression, and mechanism-of-injury as significant predictors of litigation status. MVA, compared to sports/other injuries, showed the greatest rates of litigation (OR=98.121). Higher total symptoms showed increased litigation(OR=0.238), where abuse/depression patients are less likely to pursue litigation (OR=0.063/OR=0.214)

2)     A survival analysis of unmatched patients suggested that patients engaging in litigation have a longer TTR (Litigation TTR M=293days vs. non-litigation TTR M=130days). However, a matched analysis, which grouped patients by age, #of symptoms, abuse/depression history, and mechanism-of-injury, showed no significant difference in survival time between patients based on litigation status. (Litigation TTR M=269days vs. non-litigation TTR M=223days).

While litigation patients are often stereotyped to malinger and exaggerate symptoms, this data showed that with appropriate matched analysis, there was no difference between litigation/non-litigation patients with TTR. The desire to pursue litigation may be influenced by several factors; athletes were less likely to litigate. These findings are important for physicians and attorneys to consider when tasked with focusing on recovery time in litigation cases.

Authors/Disclosures
Jennifer W. McVige, MD, FAAN (Dent Neurological Institute)
PRESENTER
Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to AAN interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to AAN interests or activities.
Dilpreet Kaur-Spencer, MD (Madigan Army Medical Center - JBLM) No disclosure on file
Michael Lillis, Jr., LMHC (Dent Neurologic Institute) No disclosure on file
No disclosure on file
No disclosure on file